浙江诚意药业股份有限公司控股股东之一致行动人减持股份计划公告

Group 1 - The controlling shareholder of Zhejiang Chengyi Pharmaceutical Co., Ltd. (hereinafter referred to as "Chengyi Pharmaceutical" or "the company") and its concerted actors plan to reduce their shareholdings [1] - As of the announcement date, the controlling shareholder Mr. Yan Yiyi holds 77,192,080 shares, accounting for 23.58% of the total share capital, while the concerted actor Wenzhou Dongtou Chengyi Microfinance Co., Ltd. holds 3,525,900 shares (1.08%), and Ms. Yan Xiaoling holds 349,722 shares (0.11%) [1] - The reduction plan involves a maximum of 3,875,622 shares, representing 1.18% of the total share capital, to be sold within three months starting from 15 trading days after the announcement [1][2] Group 2 - The reduction will be executed through centralized bidding or block trading, with the selling price determined by the market price at the time of the sale [1] - If the company undergoes any changes in total share capital due to stock dividends, capital reserve transfers, or other actions, the number and proportion of shares to be reduced will be adjusted accordingly [1] - The company will comply with relevant laws and regulations during the reduction process and fulfill its information disclosure obligations [3]